A new phase 3 trial suggests a single mRNA vaccine may protect against both COVID-19 and flu. mRNA-1083 met noninferiority criteria and showed higher immune responses than standard vaccines in adults over 50. ➡️ Watch the video and read the full JAMA study: ja.ma/3GODDMb